Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-10-04 to 2024-10-07
Current total value of award: $5739.86
Description: 4566021462!QUILLIVANT XR ORAL SUSP 60ML 5MG/ML